FierceBiotechAverting toxic side effects from CAR-T cancer treatmentsFierceBiotechTo identify the biomarkers, the research team closely tracked 133 patients participating in a trial of a CAR-T that was developed at Fred Hutch to treat chronic lymphocyt… Continue reading
National Institutes of Health (press release)NIH partners with 11 leading biopharmaceutical companies to accelerate the development of new cancer …National Institutes of Health (press release)PACT will initially focus on efforts to identify, develop … Continue reading
Swedish prosecutor says will not charge Italian stem cell surgeonBusiness InsiderSTOCKHOLM (Reuters) – Swedish prosecutors said on Thursday they were ending without charges an investigation into surgeon Paolo Macchiarini after finding no legal evidence… Continue reading
Dayton Daily NewsFDA advisers endorse gene therapy to treat form of blindnessDayton Daily NewsDr. Barry Byrne listens to testimony concerning the approval of a potentially breakthrough drug for a form of blindness during a meeting of the The Cellular, … Continue reading
OncLive |
Promising Immunotherapy Agents for NSCLC
OncLive Everett Vokes, MD: Roy, I’d like to turn to you, again, a little bit, as somebody who’s been involved in investigational therapies throughout your career. What are new, promising single agents (immunotherapy agents), and what combinations excite you as … |
|
Product News: Doulix – Agilent Collaboration to Offer New SureVector Cloning System
SelectScience Double Helix Technologies (Doulix) has announced a collaboration with Agilent Technologies Inc. to promote Agilent’s SureVector next-generation cloning kits through Doulix’s web platform. Through this partnership, synthetic biologists will be able to … |